Gen-Probe Completes Tepnel Acquisition | GenomeWeb

NEW YORK (GenomeWeb News) – Gen-Probe today said that it has completed its acquisition of Tepnel Life Sciences for £92.8 million (US$136.4 million).

The acquisition provides Gen-Probe with an entry into the transplant diagnostics market as well as genetic tests that Gen-Probe believes are complementary to its molecular diagnostics products. Tepnel also has collaborations with pharmaceutical clients to develop companion diagnostics.

Gen-Probe expects the acquisition to be neutral to its 2009 earnings per share and accretive to its 2010 EPS.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.